reata pharmaceuticals stock forecast
Reata Pharmaceuticals Stock Prediction. Reata Pharmaceuticals Stock Forecast 10-01-2022.
Earnings Beat Reata Pharmaceuticals Inc Nasdaq Reta Just Beat Analyst Forecasts And Analysts Have Been Lifting Their Forecasts
NASDAQRETAs beta value is holding at 107 while the average true range ATR indicator is currently reading 217.
. Short-term and long-term forecasts for Reata Pharmaceuticals shares. RETA shares soared 206 in the last trading session to close at 3021. The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 4300 with a high estimate of 7600 and a low.
The average price target is 5125 with a high. The Score for RETA is 37 which is 26 below its historic median score of 50 and infers higher risk than normal. Reata Pharmaceuticals Inc.
The Reata Pharmaceuticals stock prediction results are shown below and presented as a graph table and text information. Target levels support and resistance levels. Based on 6 Wall Street analysts offering 12 month price targets for Reata Pharmaceuticals in the last 3 months.
Positive dynamics for Reata Pharmaceuticals shares will prevail with. Technical analysis historical chart. Reata Pharmaceuticals Inc.
About the Reata Pharmaceuticals Inc. Reata Pharmaceuticals stock forecasts are. The Reata Pharmaceuticals stock prediction results are shown below and presented as a graph table and text information.
Forecast and historical charts. Find the latest Reata Pharmaceuticals Inc. That Reata Pharmaceuticalss share price could reach 4383 by Aug 9 2023.
The Reata Pharmaceuticals stock prediction results are shown below and presented as a graph table and text information. Reata Pharmaceuticals stock monthly and. RETA stock quote history news and other vital information to help you with your stock trading and investing.
Reata Pharmaceuticals stock forecasts are. RETA one year forecast. The average Reata Pharmaceuticals stock price prediction forecasts a.
The current Reata Pharmaceuticals RETA share price is 2875. Reata Pharmaceuticals Stock Prediction. Reata Pharmaceuticals RETA stock.
RETA share price prediction for 2022 2023 2024 2025 2026 and 2027. Reata Pharmaceuticals stock forecasts are. Reata Pharmaceuticals Stock Up 206 The businesss 50-day simple moving average is 2423 and its 200 day simple moving average is 2861.
The move was backed by solid volume with far more shares changing. Posted by Defense World Staff on Oct 16th 2022. Forecast target price for 10-01-2022.
The firm has a market. Reata Pharmaceuticals stock forecast for 2025 by month. RETA Stock Price Prediction.
Reata Pharmaceuticals stock price forecast. Target prices for 2022 2023 2024. As of 2022 October 09 Sunday current price of RETA stock is 23780 and our data indicates that the asset price has.
Reata Pharmaceuticals Stock Prediction. Reata Pharmaceuticals Inc. NASDAQRETA Get Rating s share price gapped up before the market opened on Friday.
On average Wall Street analysts predict.
Reata Pharmaceuticals Inc Reta Stock Jumps 14 5 Will It Continue To Soar
Reta Reata Pharmaceuticals Inc Dividend History Dividend Channel
Reata Pharmaceuticals Earnings Preview Reata Pharmaceuticals Nasdaq Reta Benzinga
Reata Pharmaceuticals Inc Reta Stock 10 Year History
Reata Pharmaceuticals Inc Reta Stock 10 Year History
Reata Pharmaceuticals Inc Reta Stock Price News Info The Motley Fool
Reata Pharma Finally We Have A Pdufa Nasdaq Reta Seeking Alpha
Reta Stock News Reta Reta Stock News Today Investor Alert Reata Pharmaceuticals Inc Reta Stock Youtube
Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis
Pliant Therapeutics Nasdaqgs Plrx Stock Price Quote Analysis Simply Wall St
Reata Deadline Alert Bragar Eagel Squire P C Reminds Investors That A Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals Inc And Encourages Investors To Contact The Firm Business Wire
Strong Insider Buying Could Indicate A Bottom In These 3 Stocks Nasdaq
Why Reata Pharmaceuticals Stock Moved Reta Stock Has Gained 26 Since 2017 Primarily Due To Favorable Change In Price To Sales Multiple P S Trefis
Reata Pharmaceuticals Inc 2021 Annual Report 10 K
Time To Worry Analysts Just Downgraded Their Reata Pharmaceuticals Inc Nasdaq Reta Outlook
Pix2tnk J 6n M
Reata Pharmaceuticals Inc 2021 Q2 Results Earnings Call Presentation Nasdaq Reta Seeking Alpha
Nrf2 Pathway Activators Market 2022 Impact Of Covid 19 On The Global Economy Penetration And Forecast Of Industry Demand By 2028 Reata Pharma Cayman Chemical Biophore Abcam Biogen Biovision Boc Sciences Digital Journal
Buy Reata Pharmaceuticals Stock Reta Stock Price Today News Public Com